T Hayashi1, Y Iwamoto, K Kaku, H Hirose, S Maeda. 1. Laboratory for Diabetic Nephropathy, SNP Research Centre, The Institute of Physical and Chemical Research, Yokohama, Kanagawa 230-0045, Japan.
Abstract
AIMS/HYPOTHESIS: The transcription factor 7-like 2 gene (TCF7L2) has been shown to be strongly associated with an increased risk of type 2 diabetes in white populations. To further investigate the involvement of TCF7L2 in conferring susceptibility to type 2 diabetes, we examined the association of TCF7L2 polymorphisms with type 2 diabetes in a Japanese population. SUBJECTS AND METHODS: We analysed four SNPs (rs12255372, rs7903146, rs7901695 and rs11196205) and one tetranucleotide repeat polymorphism (DG10S478) in 1,630 Japanese subjects with type 2 diabetes and 1,064 control subjects. RESULTS: All investigated polymorphisms were significantly associated with type 2 diabetes, and rs12255372 showed the strongest association (T vs G, chi2 = 9.20, p = 0.0024, odds ratio = 1.70, 95% CI = 1.20-2.41), although the frequency of the risk allele in our population was much lower than that in white populations. The microsatellite polymorphism showed an almost complete linkage disequilibrium to rs1255372 when the alleles with longer repeats (+8, +12) were considered as minor alleles and showed an association with type 2 diabetes (chi2 = 5.34, p = 0.021, odds ratio = 1.50, 95% CI = 1.06-2.12). CONCLUSIONS/ INTERPRETATION: These results indicate that TCF7L2 might be a strong candidate for conferring susceptibility to type 2 diabetes across different ethnicities.
AIMS/HYPOTHESIS: The transcription factor 7-like 2 gene (TCF7L2) has been shown to be strongly associated with an increased risk of type 2 diabetes in white populations. To further investigate the involvement of TCF7L2 in conferring susceptibility to type 2 diabetes, we examined the association of TCF7L2 polymorphisms with type 2 diabetes in a Japanese population. SUBJECTS AND METHODS: We analysed four SNPs (rs12255372, rs7903146, rs7901695 and rs11196205) and one tetranucleotide repeat polymorphism (DG10S478) in 1,630 Japanese subjects with type 2 diabetes and 1,064 control subjects. RESULTS: All investigated polymorphisms were significantly associated with type 2 diabetes, and rs12255372 showed the strongest association (T vs G, chi2 = 9.20, p = 0.0024, odds ratio = 1.70, 95% CI = 1.20-2.41), although the frequency of the risk allele in our population was much lower than that in white populations. The microsatellite polymorphism showed an almost complete linkage disequilibrium to rs1255372 when the alleles with longer repeats (+8, +12) were considered as minor alleles and showed an association with type 2 diabetes (chi2 = 5.34, p = 0.021, odds ratio = 1.50, 95% CI = 1.06-2.12). CONCLUSIONS/ INTERPRETATION: These results indicate that TCF7L2 might be a strong candidate for conferring susceptibility to type 2 diabetes across different ethnicities.
Authors: Struan F A Grant; Gudmar Thorleifsson; Inga Reynisdottir; Rafn Benediktsson; Andrei Manolescu; Jesus Sainz; Agnar Helgason; Hreinn Stefansson; Valur Emilsson; Anna Helgadottir; Unnur Styrkarsdottir; Kristinn P Magnusson; G Bragi Walters; Ebba Palsdottir; Thorbjorg Jonsdottir; Thorunn Gudmundsdottir; Arnaldur Gylfason; Jona Saemundsdottir; Robert L Wilensky; Muredach P Reilly; Daniel J Rader; Yu Bagger; Claus Christiansen; Vilmundur Gudnason; Gunnar Sigurdsson; Unnur Thorsteinsdottir; Jeffrey R Gulcher; Augustine Kong; Kari Stefansson Journal: Nat Genet Date: 2006-01-15 Impact factor: 38.330
Authors: Laura J Scott; Lori L Bonnycastle; Cristen J Willer; Andrew G Sprau; Anne U Jackson; Narisu Narisu; William L Duren; Peter S Chines; Heather M Stringham; Michael R Erdos; Timo T Valle; Jaakko Tuomilehto; Richard N Bergman; Karen L Mohlke; Francis S Collins; Michael Boehnke Journal: Diabetes Date: 2006-09 Impact factor: 9.461
Authors: Coleen M Damcott; Toni I Pollin; Laurie J Reinhart; Sandra H Ott; Haiqing Shen; Kristi D Silver; Braxton D Mitchell; Alan R Shuldiner Journal: Diabetes Date: 2006-09 Impact factor: 9.461
Authors: R Duggirala; J Blangero; L Almasy; T D Dyer; K L Williams; R J Leach; P O'Connell; M P Stern Journal: Am J Hum Genet Date: 1999-04 Impact factor: 11.025
Authors: Inga Reynisdottir; Gudmar Thorleifsson; Rafn Benediktsson; Gunnar Sigurdsson; Valur Emilsson; Anna Sigurlin Einarsdottir; Eyrun Edda Hjorleifsdottir; Gudbjorg Th Orlygsdottir; Gudrun Thora Bjornsdottir; Jona Saemundsdottir; Skarphedinn Halldorsson; Soffia Hrafnkelsdottir; Steinunn Bjorg Sigurjonsdottir; Svana Steinsdottir; Mitchell Martin; Jarema P Kochan; Brian K Rhees; Struan F A Grant; Michael L Frigge; Augustine Kong; Vilmundur Gudnason; Kari Stefansson; Jeffrey R Gulcher Journal: Am J Hum Genet Date: 2003-07-08 Impact factor: 11.025
Authors: S Omori; Y Tanaka; M Horikoshi; A Takahashi; K Hara; H Hirose; A Kashiwagi; K Kaku; R Kawamori; T Kadowaki; Y Nakamura; S Maeda Journal: Diabetologia Date: 2009-05-20 Impact factor: 10.122
Authors: M Imamura; M Iwata; H Maegawa; H Watada; H Hirose; Y Tanaka; K Tobe; K Kaku; A Kashiwagi; R Kawamori; Y Nakamura; S Maeda Journal: Diabetologia Date: 2011-09-10 Impact factor: 10.122
Authors: Daruneewan Warodomwichit; Donna K Arnett; Edmond K Kabagambe; Michael Y Tsai; James E Hixson; Robert J Straka; Michael Province; Ping An; Chao-Qiang Lai; Ingrid Borecki; Jose M Ordovas Journal: J Nutr Date: 2009-01-13 Impact factor: 4.798
Authors: Jie Wen; Tina Rönn; Anders Olsson; Zhen Yang; Bin Lu; Yieping Du; Leif Groop; Charlotte Ling; Renming Hu Journal: PLoS One Date: 2010-02-10 Impact factor: 3.240